ESElif Seymour

Elif Seymour

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Elif Seymour has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Selim Unlu

    Department of Electrical and Computer Engineering, Boston University, Boston, USA

    3 shared publications
  • John H. Connor

    Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts 02218, United States

    2 shared publications
  • Nese Lortlar Ünlü

    Department of Biomedical Engineering, Boston University, Boston, Massachusetts 02215, United States

    2 shared publications
  • Aaron F. Carlin

    Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, CA, 92093, USA; Department of Pathology, University of California, San Diego, CA, 92093, USA

    1 shared publication
  • Alex E. Clark

    Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, CA, 92093, USA

    1 shared publication
  • Eric P. Carter

    Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts 02218, United States

    1 shared publication

Latest Publications

  • Open Access

    A label-free optical biosensor-based point-of-care test for the rapid detection of Monkeypox virus

    by Mete Aslan, Elif Seymour, Howard Brickner, Alex E. Clark, Iris Celebi, Michael B. Townsend, Panayampalli S. Satheshkumar, Megan Riley, Aaron F. Carlin, M. Selim Ünlü, et al.


  • Configurable Digital Virus Counter on Robust Universal DNA Chips

    by Elif Seymour, Nese Lortlar Ünlü, Erik P. Carter, John H. Connor, M. Selim Ünlü

    Here, we demonstrate real-time multiplexed virus detection by applying a DNA-directed antibody immobilization technique in a single-particle interferometric reflectance imaging sensor (SP-IRIS). In this technique, the biosensor chip surface spotted with different DNA sequences is converted to a multiplexed antibody array by flowing antibody–DNA conjugates and allowing for specific DNA–DNA hybridization. The resulting antibody array is shown to detect three different recombinant vesicular stomatitis viruses (rVSVs), which are genetically engineered to express surface glycoproteins of Ebola, Marburg, and Lassa viruses in real time in a disposable microfluidic cartridge. We also show that this method can be modified to produce a single-step, homogeneous assay format by mixing the antibody–DNA conjugates with the virus sample in the solution phase prior to incubation in the microfluidic cartridge, eliminating the antibody immobilization step. This homogenous approach achieved detection of the model Ebola virus, rVSV-EBOV, at a concentration of 100 PFU/mL in 1 h. Finally, we demonstrate the feasibility of this homogeneous technique as a rapid test using a passive microfluidic cartridge. A concentration of 104 PFU/mL was detectable under 10 min for the rVSV-Ebola virus. Utilizing DNA microarrays for antibody-based diagnostics is an alternative approach to antibody microarrays and offers advantages such as configurable sensor surface, long-term storage ability, and decreased antibody use. We believe that these properties will make SP-IRIS a versatile and robust platform for point-of-care diagnostics applications.


  • Open Access

    Configurable Digital Virus Counter on Robust Universal DNA Chips

    by Elif Seymour, Nese Lortlar Ünlü, Eric P. Carter, John H. Connor, M. Selim Ünlü

    Here, we demonstrate real-time multiplexed virus detection by applying DNA-directed antibody immobilization technique to a single-particle interferometric reflectance imaging sensor (SP-IRIS). In this technique, the biosensor chip surface spotted with different DNA sequences is converted to a multiplexed antibody array by flowing antibody-DNA conjugates and allowing specific DNA-DNA hybridization. The resulting antibody array is shown to detect three different recombinant Vesicular Stomatitis Viruses (rVSVs) genetically engineered to express surface glycoproteins of Ebola, Marburg, and Lassa viruses in real-time in a disposable microfluidic cartridge. We also show that this method can be modified to produce a single-step, homogeneous assay format by mixing the antibody-DNA conjugates with the virus sample in solution phase prior to flowing in the microfluidic cartridge, eliminating the antibody immobilization step. This homogenous approach achieved detection of the model Ebola virus, rVSV-EBOV, at a concentration of 100 PFU/ml in 1 hour. Finally, we demonstrate the feasibility of this homogeneous technique as a rapid test using a passive microfluidic cartridge. A concentration of 10 4 PFU/ml was detectable under 10 minutes for the rVSV-Ebola virus. Utilizing DNA microarrays for antibody-based diagnostics is an alternative approach to antibody microarrays and offers advantages such as configurable sensor surface, long-term storage ability, and decreased antibody use. We believe these properties will make SP-IRIS a versatile and robust platform for point-of-care diagnostics applications.